QS Investors LLC raised its holdings in Chemours Company (The) (NYSE:CC) by 14.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 140,175 shares of the specialty chemicals company’s stock after buying an additional 17,317 shares during the period. QS Investors LLC owned about 0.08% of Chemours Company (The) worth $5,315,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CC. BlackRock Inc. raised its holdings in shares of Chemours Company (The) by 48,297.2% in the first quarter. BlackRock Inc. now owns 19,160,930 shares of the specialty chemicals company’s stock valued at $737,696,000 after purchasing an additional 19,121,339 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Chemours Company (The) by 1.2% in the first quarter. Vanguard Group Inc. now owns 18,773,273 shares of the specialty chemicals company’s stock valued at $722,771,000 after purchasing an additional 215,900 shares during the last quarter. FMR LLC raised its holdings in shares of Chemours Company (The) by 6.1% in the second quarter. FMR LLC now owns 15,830,411 shares of the specialty chemicals company’s stock valued at $600,289,000 after purchasing an additional 905,038 shares during the last quarter. State Street Corp raised its holdings in shares of Chemours Company (The) by 35.1% in the first quarter. State Street Corp now owns 5,791,792 shares of the specialty chemicals company’s stock valued at $222,987,000 after purchasing an additional 1,504,657 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of Chemours Company (The) by 10.3% in the second quarter. Renaissance Technologies LLC now owns 3,342,200 shares of the specialty chemicals company’s stock valued at $126,736,000 after purchasing an additional 310,800 shares during the last quarter. 72.90% of the stock is currently owned by hedge funds and other institutional investors.

CC has been the subject of several analyst reports. UBS AG reiterated a “sell” rating and issued a $36.00 target price (up previously from $35.00) on shares of Chemours Company (The) in a report on Wednesday, June 14th. Jefferies Group LLC reiterated a “buy” rating and issued a $48.00 target price on shares of Chemours Company (The) in a report on Friday, June 16th. BidaskClub downgraded shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a report on Saturday, June 17th. Citigroup Inc. upgraded shares of Chemours Company (The) from a “neutral” rating to a “buy” rating and increased their target price for the company from $43.00 to $45.00 in a report on Wednesday, July 5th. Finally, Zacks Investment Research downgraded shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $51.50.

Shares of Chemours Company (CC) opened at 50.61 on Friday. Chemours Company has a 12-month low of $14.41 and a 12-month high of $52.15. The company’s 50-day moving average is $50.42 and its 200-day moving average is $50.42. The stock has a market cap of $9.35 billion, a P/E ratio of 33.12 and a beta of 3.64.

Chemours Company (The) (NYSE:CC) last announced its quarterly earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.85 by $0.02. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.49 billion. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. Chemours Company (The)’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.27 EPS. On average, equities research analysts anticipate that Chemours Company will post $3.51 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Thursday, August 17th were paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date was Tuesday, August 15th. Chemours Company (The)’s payout ratio is 8.11%.

In related news, insider E Bryan Snell sold 10,000 shares of the company’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $46.24, for a total value of $462,400.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP David C. Shelton sold 13,337 shares of the company’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $48.48, for a total transaction of $646,577.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,837 shares of company stock worth $1,865,603. 1.14% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: This news story was reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.watchlistnews.com/qs-investors-llc-acquires-17317-shares-of-chemours-company-the-cc/1601203.html.

Chemours Company (The) Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.